Barclays’s Genprex GNPX Stock Holding History
Bought
Maintained
Sold
Other funds holding GNPX
HF
EGM
MFA
TRCT
CVM
Barclays's GNPX Position: Q2 2026 in Review
Barclays opened a new position in Genprex (GNPX) in Q2 2026: 72 shares worth $819. The stake represents ﹤0.01% of the portfolio and ranks #4950 among its holdings. This is a return to the name: Barclays previously reported a position in GNPX as recently as Q1 2021.
Barclays first reported a position in GNPX in Q2 2020 and has held it in 3 quarters since. The position peaked at $247K in Q2 2020. 17 funds tracked by Wall St. Rank hold GNPX as of Q2 2026.
- Barclays held 72 shares of Genprex worth $819 as of Q2 2026.
- Genprex was a new Barclays position in Q2 2026.
- Genprex made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4950 holding.
- Barclays first reported a position in Genprex in Q2 2020 and has held it in 3 quarters since.
- Barclays's Genprex position peaked at $247K in Q2 2020.
- 17 funds tracked by Wall St. Rank held Genprex as of Q2 2026.
Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.